Outcomes for critically ill hematology/oncology and hematopoietic cell transplant patients, while improved over the last two decades, remain unacceptably poor compared with other patients we care for in our ICUs. The goal of this symposium is to advance the care of critically ill pediatric hematology/oncology patients through improvements in patient care, multidisciplinary collaboration, as well as clinical and translational research.
Onco-Critical Care Fundamentals Day
Tuesday, April 16th
This educational pre-day will describe current literature and management of oncologic specific emergencies in critical care in all potential settings (including middle- and lower-income settings) and outline key differences between critically ill oncologic patients and critically ill general pediatric patients. Topics this year will include sepsis, neurologic dysfunction, tumor lysis syndrome, and ventilator management in pediatric oncology patients. Sessions will be lectures followed by expert panel discussion. Please bring all your questions!
Price is $50 for general and $15 for global participants.
Registration type In-person attendance Virtual attendees Physicians, Advanced Practice Providers, Nurses, and Respiratory Therapists $200 until January 3, 2024
$300 after January 3, 2024
$175 until January 3, 2024
$275 after January 3, 2024
Medical Trainees (Students, Residents, Fellows) $150 until January 3, 2024
$175 after January 3, 2024
$100 until January 3, 2024
$125 after January 3, 2024
Low to Middle Income Countries (LMIC) attendees $25 $25 St. Jude Children's Research Hospital and Le Bonheur Children's Hospital employees and trainees $75 $75 Onco-Critical Care Fundamentals Day (Tuesday, April 16) $50 $15 Note: In-person registration closes Wednesday, April 3, 2024. Virtual registration will remain open until close of the event.
Hotel Information to come
Topics to include Advances in Treatment for Graft Versus Host Disease, Reducing ICU Mortality in Pediatric Onco-Critical Care: Past, Present and Future, Tracheostomy: Selection and Timing in the Pediatric Onco-Critical Care Patient, Development of Clinical Pathways in Onco-Critical Care, Moral Distress in Critically Ill Pediatric Oncology Patients, and Global POCCS.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of St. Jude Children’s Research Hospital and Le Bonheur Children's Hospital/University of Tennessee Health Science Center. St. Jude Children’s Research Hospital is accredited by the ACCME to provide continuing medical education for physicians.
St. Jude Children's Research Hospital is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Evaluation and Claiming Certificates
To claim AMA PRA Category 1 CreditTM, Nursing Continuing Professional Development Credit, or attendance credit for this activity, you must attend the sessions, complete the evaluation, and follow the instructions at the end of the evaluation to claim your credit. If you have questions about claiming your CME, NCPD, or attendance certificate, please contact us at firstname.lastname@example.org. The evaluation will be available after the symposium and will be open until July 20, 2024; you will not be able to claim credit after the evaluation is closed.
Disclosure of Financial Relationships
All individuals in a position to control the content of this CE activity (such as faculty, presenters, and planners) were asked to complete a statement regarding all financial relationships between themselves and any ineligible company (defined by the ACCME as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients).
All relevant relationships will be disclosed below.
- Abstracts must be submitted online via the website only. Abstracts submitted by email will NOT be accepted.
- All abstracts must be submitted and presented in English with accurate grammar and spelling of a quality suitable for publication. Authors who would like assistance with the English writing of their abstract should contact us at POCCS@stjude.org at least 2 weeks prior to the deadline. Those part of the Global Critical Care Program should email email@example.com at least 2 weeks prior to the deadline.
- Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.
- Instructions for preparation of presentations/posters will be made available closer to the date of the congress.
Before submitting your abstract or case report, please prepare the following information:
- Presenting author’s and co-authors’ contact details:
- Full first and family name(s)
- Email address
- Affiliation details: department, institution/hospital, city, state (if relevant), country
- Use a concise title (max 25 words)
- Abstracts are limited to 2000 characters (approximately 300 words)
- Tables and graphics must be inserted in a .jpg or .pdf format. Please limit to one table or figure. However, tables and graphics are not required.
- Abstract content should be single spaced and should clearly contain:
- Background and purpose
- Use only standard abbreviations and use generic names of drugs.
- Submissions may not contain patient names, hospital ID numbers or other identifying information.
- Do not begin sentences with a number – type the number in full; for example, “Three patients” instead of ”3 patients.”
- Abstracts stating “data will be discussed in the presentation” will NOT be accepted.
- Please do not submit multiple copies of the same abstract.
- Presenting author’s and co-authors’ contact details:
- All abstracts will be evaluated anonymously and scored by the appropriate Scientific Committee. The committee will determine whether the abstract will be accepted for poster presentation and journal publication.
- The deadline to submit abstracts is Friday, December 15, 2023 at 11:59pm
- Acceptance notifications for presentation will be sent in January 2024.